CSBR · Champions Oncology, Inc.
$5.26
-0.20 (-3.66%)
At close · Jul 30
Market Cap
$73.08M
Shares
13.89M
Champions Oncology, Inc. Earnings Call Transcripts
Every quarterly earnings call for Champions Oncology, Inc. (CSBR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲22.1%
$13.74M
−$319,000
'23 Q1
22-09-08
▲21.2%
$14.28M
−$16,000
'23 Q2
22-12-13
▼3.2%
$12.77M
−$2.44M
'23 Q3
23-03-15
▲1.5%
$13.07M
−$2.56M
'23 Q4
23-07-24
▼8.6%
$12.56M
−$2.57M
'24 Q1
23-09-13
▼19%
$11.57M
−$2.07M
'24 Q2
23-12-12
▼5.9%
$12.02M
−$2.53M
'24 Q3
24-03-12
▲7.1%
$14.00M
−$109,000
'24 Q4
24-07-18
▲11.9%
$14.06M
$1.31M
'25 Q1
24-09-11
▲16.6%
$13.49M
$728,000
'25 Q2
24-12-11
▲41.8%
$17.04M
$4.50M
'25 Q3
25-03-11
▼11.8%
$12.36M
−$1.83M
'25 Q4
25-07-23
▼0.5%
$13.99M
−$436,000
'26 Q1
25-09-15
▲11.5%
$15.04M
$268,000
'26 Q2
25-12-15
▼2.8%
$16.56M
−$279,000
'26 Q3
26-03-12
LATEST
▲12%
$13.84M
−$728,000
'26 Q4
26-07-27
Earnings call
FY26 · Q4
2026-07-27
Champions Oncology, Inc. Q4 FY2026 Earnings Call
Revenue
$13.84M*
▲ 12% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-03-12
Champions Oncology, Inc. Q3 FY2026 Earnings Call
Positive tone
Services revenue growth and operational performance
Data business momentum and pipeline
Investment in data platform and Discovery Therapeutics
Revenue
$16.56M
▼ 2.8% YoY Diluted EPS
$-0.02
▼ 106.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2025-12-15
Champions Oncology, Inc. Q2 FY2026 Earnings Call
Revenue
$15.04M
▲ 11.5% YoY Diluted EPS
$0.02
▼ 60% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-09-15
Champions Oncology, Inc. Q1 FY2026 Earnings Call
Revenue
$13.99M
▼ 0.5% YoY Diluted EPS
$-0.03
▼ 133.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-07-23
Champions Oncology, Inc. Q4 FY2025 Earnings Call
Confident tone
Data licensing platform
Turnaround and return to profitability
Core research services business
Revenue
$12.36M*
▼ 11.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-03-11
Champions Oncology, Inc. Q3 FY2025 Earnings Call
Revenue
$17.04M
▲ 41.8% YoY Diluted EPS
$0.31
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2024-12-11
Champions Oncology, Inc. Q2 FY2025 Earnings Call
Revenue
$13.49M
▲ 16.6% YoY Diluted EPS
$0.05
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-09-11
Champions Oncology, Inc. Q1 FY2025 Earnings Call
Revenue
$14.06M
▲ 11.9% YoY Diluted EPS
$0.09
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-07-18
Champions Oncology, Inc. Q4 FY2024 Earnings Call
Revenue
$14.00M*
▲ 7.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-03-12
Champions Oncology, Inc. Q3 FY2024 Earnings Call
Revenue
$12.02M
▼ 5.9% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2023-12-12
Champions Oncology, Inc. Q2 FY2024 Earnings Call
Revenue
$11.57M
▼ 19% YoY Diluted EPS
$-0.15
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-09-13
Champions Oncology, Inc. Q1 FY2024 Earnings Call
Revenue
$12.56M
▼ 8.6% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-07-24
Champions Oncology, Inc. Q4 FY2023 Earnings Call
Revenue
$13.07M*
▲ 1.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-03-15
Champions Oncology, Inc. Q3 FY2023 Earnings Call
Revenue
$12.77M
▼ 3.2% YoY Diluted EPS
$-0.18
▼ 460% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2022-12-13
Champions Oncology, Inc. Q2 FY2023 Earnings Call
Revenue
$14.28M
▲ 21.2% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-09-08
Champions Oncology, Inc. Q1 FY2023 Earnings Call
Revenue
$13.74M
▲ 22.1% YoY Diluted EPS
$-0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-07-21
Champions Oncology, Inc. Q4 FY2022 Earnings Call
Revenue
$12.88M*
▲ 21.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-03-15
Champions Oncology, Inc. Q3 FY2022 Earnings Call
Revenue
$13.19M
▲ 22% YoY Diluted EPS
$0.05
▼ 28.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2021-12-13
Champions Oncology, Inc. Q2 FY2022 Earnings Call
Revenue
$11.79M
▲ 16.5% YoY Diluted EPS
$0.02
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-09-13
Champions Oncology, Inc. Q1 FY2022 Earnings Call
Revenue
$11.25M
▲ 17.9% YoY Diluted EPS
$-0.01
▼ 200% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-07-22
Champions Oncology, Inc. Q4 FY2021 Earnings Call
Revenue
$10.56M*
▲ 20.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-03-11
Champions Oncology, Inc. Q3 FY2021 Earnings Call
Revenue
$10.81M
▲ 20% YoY Diluted EPS
$0.07
▲ 133.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2020-12-14
Champions Oncology, Inc. Q2 FY2021 Earnings Call
Revenue
$10.12M
▲ 32.7% YoY Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-09-14
Champions Oncology, Inc. Q1 FY2021 Earnings Call
Revenue
$9.55M
▲ 41.7% YoY Diluted EPS
$0.01
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-07-27
Champions Oncology, Inc. Q4 FY2020 Earnings Call
Revenue
$8.75M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-03-12
Champions Oncology, Inc. Q3 FY2020 Earnings Call
Revenue
$9.01M
▲ 40.2% YoY Diluted EPS
$0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2019-10-31
Champions Oncology, Inc. Q2 FY2020 Earnings Call
Revenue
$7.62M
▲ 13.9% YoY Diluted EPS
$0.02
▲ 0% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–27 of 27 earnings calls